Impact of laparoscopic gastrectomy on relapse-free survival for locally advanced gastric cancer patients with sarcopenia: a propensity score matching analysis

被引:3
作者
Matsui, Ryota [1 ,2 ]
Inaki, Noriyuki [1 ,3 ]
Tsuji, Toshikatsu [1 ]
机构
[1] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol Surg, Kanazawa, Ishikawa, Japan
[2] Juntendo Univ Urayasu Hosp, Dept Surg, Urayasu, Japan
[3] Kanazawa Univ, Dept Gastrointestinal Surg Breast Surg, Grad Sch Med Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2022年 / 36卷 / 07期
关键词
Gastric cancer; Laparoscopic gastrectomy; Prognosis; Relapse-free survival; Sarcopenia; OPEN DISTAL GASTRECTOMY; LEAN BODY-MASS; S-1 ADJUVANT CHEMOTHERAPY; INDEPENDENT RISK-FACTOR; LYMPH-NODE DISSECTION; WEIGHT-LOSS; D2; GASTRECTOMY; POOR SURVIVAL; METAANALYSIS; CONTINUATION;
D O I
10.1007/s00464-021-08812-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Recent gastric cancer reports have shown that preoperative sarcopenia worsens long-term prognosis after gastrectomy. We investigated the impact of laparoscopic surgery on the long-term prognosis of locally advanced gastric cancer patients with sarcopenia. Methods This retrospective study included consecutive patients who underwent radical gastrectomy for primary c-stage II or III advanced gastric cancer, between April 2008 and April 2017, with computed tomography records of skeletal muscle mass. The skeletal muscle mass index was calculated, and sarcopenia was defined when values were below the cut-off. The patients were divided into a laparoscopy group and open group, in which the background was adjusted using propensity score matching; the relapse-free survival and overall survival were compared between them. The prognostic factors for relapse-free survival and overall survival were investigated by multivariate analyses. Results This study included 141 patients with sarcopenia (laparoscopy group, n = 69 [48.9%]; open group, n = 72 [51.1%]). After matching, there were 50 patients in both groups, with no significant differences in patient background. The median follow-up period was 38 months. Relapse-free survival was worse in the open group (hazard ratio: 1.662, 95% confidence interval: 0.910-3.034; P = 0.098), but there was no difference in the overall survival (P = 0.181). Multivariate analysis concluded that open surgery is an independent prognostic factor of relapse-free survival (hazard ratio: 3.219, 95% confidence interval: 1.381-7.502; P = 0.007) but not of OS. Conclusion Compared with the open surgery group, the laparoscopy group had a better RFS, although the difference was not statistically significant.
引用
收藏
页码:4721 / 4731
页数:11
相关论文
共 37 条
  • [1] The postoperative lean body mass loss at one month leads to a poor survival in patients with locally advanced gastric cancer
    Aoyama, Toru
    Yoshikawa, Takaki
    Maezawa, Yukio
    Kano, Kazuki
    Numata, Masakatsu
    Hara, Kentaro
    Komori, Keisuke
    Yamada, Takanobu
    Hayashi, Tsutomu
    Sato, Tsutomu
    Tamagawa, Hiroshi
    Yukawa, Norio
    Rino, Yasushi
    Masuda, Munetaka
    Ogatal, Takashi
    Cho, Haruhiko
    Oshima, Takashi
    [J]. JOURNAL OF CANCER, 2019, 10 (11): : 2450 - 2456
  • [2] A Comparison of the Body Composition Changes Between Laparoscopy-assisted and Open Total Gastrectomy for Gastric Cancer
    Aoyama, Toru
    Yoshikawa, Takaki
    Maezawa, Yukio
    Kano, Kazuki
    Hara, Kentaro
    Sato, Tsutomu
    Hayashi, Tsutomu
    Yamada, Takanobu
    Cho, Haruhiko
    Ogata, Takashi
    Tamagawa, Hiroshi
    Yukawa, Norio
    Rino, Yasushi
    Masuda, Munetaka
    Oshima, Takashi
    [J]. IN VIVO, 2018, 32 (06): : 1513 - 1518
  • [3] Does a laparoscopic approach attenuate the body weight loss and lean body mass loss observed in open distal gastrectomy for gastric cancer? a single-institution exploratory analysis of the JCOG 0912 phase III trial
    Aoyama, Toru
    Sato, Tsutomu
    Hayashi, Tsutomu
    Yamada, Takanobu
    Cho, Haruhiko
    Ogata, Takashi
    Oba, Koji
    Yoshikawa, Takaki
    [J]. GASTRIC CANCER, 2018, 21 (02) : 345 - 352
  • [4] Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer
    Aoyama, Toru
    Sato, Tsutomu
    Maezawa, Yukio
    Kano, Kazuki
    Hayashi, Tsutomu
    Yamada, Takanobu
    Yukawa, Norio
    Oshima, Takashi
    Rino, Yasushi
    Masuda, Munetaka
    Ogata, Takashi
    Cho, Haruhiko
    Yoshikawa, Takaki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (03) : 476 - 483
  • [5] Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer
    Aoyama, Toru
    Kawabe, Taiichi
    Fujikawa, Hirohito
    Hayashi, Tsutomu
    Yamada, Takanobu
    Tsuchida, Kazuhito
    Yukawa, Norio
    Oshima, Takashi
    Rino, Yasushi
    Masuda, Munetaka
    Ogata, Takashi
    Cho, Haruhiko
    Yoshikawa, Takaki
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (08) : 2560 - 2566
  • [6] Body Weight Loss After Surgery is an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer
    Aoyama, Toru
    Yoshikawa, Takaki
    Shirai, Junya
    Hayashi, Tsutomu
    Yamada, Takanobu
    Tsuchida, Kazuhito
    Hasegawa, Shinichi
    Cho, Haruhiko
    Yukawa, Norio
    Oshima, Takashi
    Rino, Yasushi
    Masuda, Munetaka
    Tsuburaya, Akira
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (06) : 2000 - 2006
  • [7] Adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis
    Cao, Jisen
    Qi, Feng
    Liu, Tong
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (06) : 690 - 704
  • [8] Systematic Review and Meta-analysis of Laparoscopic Versus Open Distal Gastrectomy
    Cheng, Qiuye
    Pang, Tony C. Y.
    Hollands, Michael J.
    Richardson, Arthur J.
    Pleass, Henry
    Johnston, Emma S.
    Lam, Vincent W. T.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2014, 18 (06) : 1087 - 1099
  • [9] Sarcopenia: European consensus on definition and diagnosis
    Cruz-Jentoft, Alfonso J.
    Baeyens, Jean Pierre
    Bauer, Juergen M.
    Boirie, Yves
    Cederholm, Tommy
    Landi, Francesco
    Martin, Finbarr C.
    Michel, Jean-Pierre
    Rolland, Yves
    Schneider, Stephane M.
    Topinkova, Eva
    Vandewoude, Maurits
    Zamboni, Mauro
    [J]. AGE AND AGEING, 2010, 39 (04) : 412 - 423
  • [10] Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer
    Daly, Louise E.
    Ni Bhuachalla, Eadaoin B.
    Power, Derek G.
    Cushen, Samantha J.
    James, Karl
    Ryan, Aoife M.
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2018, 9 (02) : 315 - 325